Abstract
Tectonic-1, also named as TCTN1 or TECT1, which belongs to a family of signal-sequence-containing secreted and transmembrane proteins evolutionarily conserved among eukaryotes, was reported to be involved in central nervous system development and ciliogenesis. In this paper, we found that TCTN1 is extensively expressed in human glioma cell lines. To clarify the role of TCTN1 in glioma, we employed lentivirus-mediated short hairpin RNA to knock down TCTN1 expression in U251 and U87MG glioma cells. Knockdown of TCTN1 potently inhibited cell proliferation, as determined by MTT and colony formation assays. Cell cycle analysis showed depletion of TCTN1 led to both U251 and U87MG cells arrested in the G0/G1 phase. These data suggest TCTN1 is essential for glioma cell viability, and dysregulation of TCTN1 may play a key role in glioma tumorigenesis.
Similar content being viewed by others
References
Fadul, C. E., Wen, P. Y., Kim, L., & Olson, J. J. (2008). Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme. Journal of Neuro-Oncology, 89, 339–357.
Garcia-Gonzalo, F. R., Corbit, K. C., Sirerol-Piquer, M. S., Ramaswami, G., Otto, E. A., Noriega, T. R., Seol, A. D., Robinson, J. F., Bennett, C. L., Josifova, D. J., Garcia-Verdugo, J. M., Katsanis, N., Hildebrandt, F., & Reiter, J. F. (2011). A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. Nature Genetics, 43, 776–784.
Gonzalez-Alegre, P., Bode, N., Davidson, B. L., & Paulson, H. L. (2005). Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25, 10502–10509.
Goodenberger, M. L., & Jenkins, R. B. (2012). Genetics of adult glioma. Cancer Genetics, 205, 613–621.
Harper, S. Q., Staber, P. D., Beck, C. R., Fineberg, S. K., Stein, C., Ochoa, D., & Davidson, B. L. (2006). Optimization of feline immunodeficiency virus vectors for RNA interference. Journal of Virology, 80, 9371–9380.
Hartwell, L. H., & Kastan, M. B. (1994). Cell cycle control and cancer. Science, 266, 1821–1828.
Ingham, P. W., Nakano, Y., & Seger, C. (2011). Mechanisms and functions of Hedgehog signalling across the metazoa. Nature Reviews. Genetics, 12, 393–406.
Jiang, J., & Hui, C. C. (2008). Hedgehog signaling in development and cancer. Developmental Cell, 15, 801–812.
Lum, L., & Beachy, P. A. (2004). The Hedgehog response network: sensors, switches, and routers. Science, 304, 1755–1759.
Malumbres, M., & Barbacid, M. (2009). Cell cycle. CDKs and cancer: a changing paradigm. Nature Reviews. Cancer, 9, 153–166.
Nakamura, M., & Katano, M. (2008). Hedgehog signaling pathway and its impact on development of cancer therapy. Fukuoka Igaku zasshi = Hukuoka Acta Medica, 99, 102–106.
Reiter, J. F., & Skarnes, W. C. (2006). Tectonic, a novel regulator of the Hedgehog pathway required for both activation and inhibition. Genes & Development, 20, 22–27.
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., Gertler, F. B., Scott, M. L., & Van Parijs, L. (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genetics, 33, 401–406.
Schwartz, G. K., & Shah, M. A. (2005). Targeting the cell cycle: a new approach to cancer therapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23, 9408–9421.
Wang, L., Wei, Q., Wang, L. E., Aldape, K. D., Cao, Y., Okcu, M. F., Hess, K. R., El-Zein, R., Gilbert, M. R., Woo, S. Y., Prabhu, S. S., Fuller, G. N., & Bondy, M. L. (2006). Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24, 1627–1632.
Yin, L. T., Fu, Y. J., Xu, Q. L., Yang, J., Liu, Z. L., Liang, A. H., Fan, X. J., & Xu, C. G. (2007). Potential biochemical therapy of glioma cancer. Biochemical and Biophysical Research Communications, 362, 225–229.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, J., Wang, H., Hang, C. et al. Lentivirus-Mediated Knockdown of TCTN1 Inhibits Glioma Cell Proliferation. Appl Biochem Biotechnol 176, 13–21 (2015). https://doi.org/10.1007/s12010-015-1498-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-015-1498-1